1 Report Outline
1.1 Report Scope
1.2 Market Definitions
1.3 Research Methodology
1.4 Report Assumptions and Declarations
2 Executive Summary
3 Market Positioning
3.1 Total Addressable Market (TAM): Medical Aesthetics Industry
3.2 Segmented Addressable Market (SAM): Facial Injectables Market
3.2.1 Market Overview
3.2.2 Major Trends
3.2.3 PEST Analysis
3.3 Related Markets
4 Market Outlook
4.1 Overview
4.2 Value Chain Analysis
4.3 Market Segmentation
4.4 Porter 5 (Five) Forces Analysis
4.5 Raw Material Analysis
4.6 Patents Analysis
5 Market Characteristics
5.1 Ecosystem
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.2 Restraints
5.3.3 Opportunities
5.3.4 DRO - Impact Analysis
6 Facial Injectables Market by Types: Market Size and Analysis
6.1 Overview
6.2 Dermal Fillers
6.3 Botox
7 Facial Injectables Market by End Users: Market Size and Analysis
7.1 Overview
7.2 Hospitals
7.3 Dermatology Centers
7.4 Physician's Office
8 Facial Injectables Market by Regions: Market Size and Analysis
7.1 Overview
7.2 The Americas
7.3 The EMEA Region
7.4 The APAC region
8 Competitive Landscape
8.1 Overview
9 Vendor Profiles
9.1 Allergan Plc
8.2 Galderma S.A.
8.3 Merz Pharma GmbH & Co. KGaA
8.4 Ipsen S.A.
(Overview' products/services' geographic revenues' recent developments' business focus' SWOT analysis and business strategy for all vendors)
9 Companies to Watch For
9.1 Sinclair Pharma Plc
9.2 Bloomage Biotechnology Corp. Ltd.
9.3 Valeant Pharmaceuticals International Inc.
(Overview' product coverage and potential' geographic exposure' recent developments' and business strategy for all players)
Annexure
Acronyms